Clinical Observation on Non - small Cell Lung Carcinoma Treated by Jinfukang Oral Solution
- VernacularTitle:金复康口服液治疗非小细胞肺癌的临床观察
- Author:
Jiaxiang LIU
;
Zhiming SHI
;
Zhenye XU
- Publication Type:Journal Article
- Keywords:
Lung tumor/TCM therapy Cancer, small cell/TCM therapy@Jinfukang oral solution
- From:
Journal of Traditional Chinese Medicine
1992;0(12):-
- CountryChina
- Language:Chinese
-
Abstract:
In view of the deficiencies of both Qi and Yin in most cases of this tumor, Jinfukang oral solution (JFK). a remedy mainly for benefiting Qi and nourishing -yin. was formulated. 96 cases were treated with one case of CR. 8 cases PR, 52 NC. the rate of PR + NC being 63. 5%. Another 52 cases were treated with chemotherapy +JFK. with 11 cases of PR, 26 cases NC, the rate of PR + NC being 71. 2%. While 25 cases were treated by chemotherapy alone, the cases of PR was 4; NC 26. the rate of PR + NC being 60. 0%, This demonstrated that the effect of JFK and JFK + chemotherapy were all superior to effect of chemotherapy alone. For 1 - and 2 - year survival rates, the JFK group was 67. 3% and 66. 7% respectively, whereas that of JFK + chemotherapy. 67. 3% and 66. 7%. For the chemotherapy group , 1 - year survival rate was 40. 3%, with no survivals within 2 years. For symptom improvement, body weight gaining, and health condition (KPS evaluation) after treatment, the JFK and JFK + chemotherapy groups were, again, superior to the chemotherapy group. The Immunity indices and blood picture in JFK group after treatment were markedly improved as compared with those before treatment, but, those in the chemotherapy group were decreased, while those of the JFK + chemotherapy group remained unchanged.
